Latest / The Best of the Money Show / Market commentary with Siya Mbatha: 5th October2026
Transcript
- 0:00Speaker 1: The Money Show.
- 0:01Speaker 2: The Markets. Sia Mbatis, an investment analyst at the old
- 0:04Speaker 2: Mutual Investment Group. Sia, good evening. The Sanlam Santam deal.
- 0:09Speaker 2: I knew I was going to mess it up at
- 0:10Speaker 2: one point. Suddenly, a lot of money on the table. Certainly,
- 0:15Speaker 2: the people I've heard from so far think it's a
- 0:17Speaker 2: good deal.
- 0:17Speaker 1: Certainly, Stephen. Good evening. At first glance, I think you
- 0:22Speaker 1: could argue that Sondheim is taking advantage of the depressed valuation.
- 0:27Speaker 1: So Sondheim is trading at a pretty significant discount to
- 0:30Speaker 1: its own earnings multiple, so roughly 33%. But I think
- 0:35Speaker 1: the interesting question is whether that makes the transaction attractive
- 0:37Speaker 1: for Sundam itself. And one could argue that actually there
- 0:41Speaker 1: aren't really significant synergies here. So Sundam is already integrated
- 0:45Speaker 1: into Sundam, already operating efficiently. This isn't a traditional M &
- 0:50Speaker 1: A transaction where you're buying a business and you're unlocking
- 0:53Speaker 1: a huge amount of cost savings. So a lot of
- 0:56Speaker 1: the benefit is really about simplifying the structure and management
- 0:59Speaker 1: have alluded to this. And then you have to think
- 1:01Speaker 1: about the balance sheet. So the transaction is debt funded
- 1:05Speaker 1: and that will, of course, increase Sundance financial leverage. They
- 1:08Speaker 1: wouldn't be breaching their limits, but they are using a
- 1:11Speaker 1: meaningful amount of their remaining balance sheet capacity. And so
- 1:15Speaker 1: I think for me, it really is an opportunity cost question.
- 1:18Speaker 1: Is owning the remaining 38% of Sundance really the best
- 1:21Speaker 1: use of Sundance capital right now? because Sunterm already controls it.
- 1:26Speaker 1: It's a business that they know very well. So I
- 1:28Speaker 1: think that, for me, is the interesting tension in the debate.
- 1:30Speaker 1: It's not really whether Sunterm is a good business. It
- 1:34Speaker 1: clearly is, but I think it really is about whether
- 1:37Speaker 1: the incremental value from owning it will justify deploying capital
- 1:43Speaker 1: into Sunterm.
- 1:45Speaker 2: Sapi, the papermaker, they've entered into plans for a joint
- 1:48Speaker 2: venture with another papermaker in the EU called UPM. The
- 1:52Speaker 2: EU now suggesting actually they might not be so keen
- 1:55Speaker 2: on that. Yes.
- 1:57Speaker 1: So maybe just to take a step back. So SAPI
- 2:00Speaker 1: has derated quite significantly. And relative to history, you know,
- 2:06Speaker 1: even the sector, it trades at a discount. So the
- 2:08Speaker 1: market is clearly worried about the structural decline in graphic paper,
- 2:13Speaker 1: SAPI's cost base, and most importantly, the debt that currently
- 2:16Speaker 1: sits on the balance sheet. But the swing factor for
- 2:19Speaker 1: me was the UPMJV, right? So the deal was designed
- 2:23Speaker 1: to combine the European graphic paper businesses, take out costs
- 2:28Speaker 1: and generate about 100 million euros worth of annual savings, right?
- 2:32Speaker 1: But the problem, of course, that you mentioned is that
- 2:35Speaker 1: the European Commission has not issued a statement of objections.
- 2:39Speaker 1: And they're arguing that this deal could potentially reduce competition
- 2:43Speaker 1: and lead to higher prices and, of course, less customer choice.
- 2:46Speaker 1: And that puts a big question mark over the recovery thesis, right?
- 2:49Speaker 1: Because the JV was one of the mechanisms intended to
- 2:53Speaker 1: address the structural problem in European graphic paper. But I
- 2:57Speaker 1: think for SAPI investment case, you don't need graphic paper
- 3:00Speaker 1: to become a growth industry for it to work. You
- 3:03Speaker 1: just need a little bit of improvements in pricing, some
- 3:06Speaker 1: set PM2 to deliver, and of course, some of the
- 3:09Speaker 1: costs to normalize and cash flow to recover, right? So
- 3:12Speaker 1: it definitely is a leveraged story. But, you know, now
- 3:17Speaker 1: the key question is whether the strategic restructuring actually happens
- 3:20Speaker 1: and whether the deal goes through.
- 3:22Speaker 2: Lots of talk about SPAR over the last couple of weeks.
- 3:25Speaker 2: The share price has sort of been dropping, really. Perisex
- 3:28Speaker 2: increased their stake. Sure.
- 3:30Speaker 1: I mean, it was quite interesting. So in September, they
- 3:33Speaker 1: disclosed that they went from about 30 bps to 6.25%,
- 3:38Speaker 1: which is quite significant. And then, of course, again, today,
- 3:41Speaker 1: they've gone from 8% to 10%. But you have to
- 3:43Speaker 1: be careful there. So Parasite is a prime broker. So
- 3:46Speaker 1: they don't necessarily mean that Parasite itself has taken a
- 3:50Speaker 1: fundamental view on SPAR. They're most likely buying on behalf
- 3:53Speaker 1: of their clients. And of course, the sense doesn't tell
- 3:56Speaker 1: us who this is or what the strategy is, but
- 3:59Speaker 1: the That's likely what's currently happening. But I think it
- 4:02Speaker 1: does raise a question, right? So why would a long-earning
- 4:05Speaker 1: investor be building a position now? You'd have to go
- 4:09Speaker 1: back to the voluntary update. That wasn't particularly pretty. The
- 4:14Speaker 1: second half earnings are expected to come down and, of course,
- 4:17Speaker 1: full-year earnings are expected to come down, and that's largely known.
- 4:20Speaker 1: And most importantly, the balance sheet is looking a lot
- 4:23Speaker 1: less concerning now. So net debt is expected to come down.
- 4:26Speaker 1: So the risk of rights issues significantly fallen. And operationally,
- 4:30Speaker 1: the turnaround is taking longer than expected. But I guess
- 4:33Speaker 1: that's potentially the opportunity, right? So you don't need SPA, again,
- 4:36Speaker 1: to become a great business. You just need a little
- 4:39Speaker 1: bit of incremental improvements, a little bit of operational inefficiencies
- 4:43Speaker 1: to be fixed here. Cash flow to recover and, of course,
- 4:46Speaker 1: the leverage to come down. But I guess the crown
- 4:50Speaker 1: jewel with Ireland continuing to perform well, I think there
- 4:53Speaker 1: is a credible argument that investors could be positioning ahead
- 4:56Speaker 1: of recovery rather than waiting for the numbers to show up.
- 5:00Speaker 2: Sia Mbata, thanks so much. Investment analyst at the Old
- 5:02Speaker 2: Mutual Investment Group.